Articolul precedent |
Articolul urmator |
![]() |
![]() ![]() |
Ultima descărcare din IBN: 2024-03-10 20:39 |
![]() NICOLAI, Eugeniu, VÎSLOUH, Oxana, VALICA, Vladimir, PARII, Sergiu, UNCU, Livia. Studii de stabilitate a picăturilor auriculare combinate pentru tratamentul otitelor. In: Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină şi Farmacie „Nicolae Testemiţanu”, 21-23 octombrie 2020, Chişinău. Chişinău: USMF, 2020, p. 673. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” 2020 | ||||||
Congresul "Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină şi Farmacie „Nicolae Testemiţanu”" Chişinău, Moldova, 21-23 octombrie 2020 | ||||||
|
||||||
Pag. 673-673 | ||||||
|
||||||
![]() |
||||||
Rezumat | ||||||
Background. The studied combined ear drops have an increased tendency of degradation, which requires an extensive stability study and obtaining data to determine the shelf life and establish the storage conditions. Objective of the study. Stability studies of ear drops containing ciprofloxacin, dexamethasone, loratadine and volatile basil oil. Material and Methods. ICH Q1A (R2) stability testing methodology; 3 series of ear drops; reference standards for the active substances (Sigma Aldrich, USA); Shimadzu LC-20AD liquid chromatograph with UV-VIS detector; Fungilab Smart R viscometer; pH meter inoLab 7110; solvents, reagents in accordance with the European Pharmacopoeia. Results. Ciprofloxacin is stable in acidic medium, degrades in alkaline medium after 3 hours (approximately 10.0%), under oxidation (19.7%) and light action (17.1%). Dexamethasone degrades in acidic medium (by 7.7%) and under oxidation (by 19.9%), it is stable in alkaline medium and under the action of light. Loratadine degrades in acidic medium (by 3.0%), is stable in alkaline medium, under oxidation and action of light. In real-time storage conditions (25°C±2°C and UR 60%±5%), it was found that the pharmaceutical form did not change its quality parameters for 24 months. Conclusion. The stability studies under stress and in real time conditions allowed us to select the packaging, the optimal storage conditions and to establish the provisional shelf life for the combined auricular pharmaceutical form during 2 years. |
||||||
Cuvinte-cheie stability, combined ear drops, otitis, Shelf life, stabilitate, picături otice combinate, otite, termen de valabilitate |
||||||
|